The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.b

Antiphospholipid antibodies w/wo the APL syndrome

Publications

Gérardin C, Bihan K, Salem JE, Khachatryan H, Gerotziafas G, Fain O, Mekinian A

Drug-induced antiphospholipid syndrome: Analysis of the WHO international database.

Autoimmunity reviews 2022 May;21 — 2022 May — 103060

Ben Salem C

The pathogenesis of the antiphospholipid syndrome.

The New England journal of medicine 2013 06 13;368;2334 — 2013 06 13 — 2334

Aouba A, Georgin-Lavialle S, Terrier B, Guillevin L, Authier FJ

Anti-PL7 antisynthetase syndrome under interferon therapy.

Joint, bone, spine : revue du rhumatisme 2011 Jan;78;94-7 — 2011 Jan — 94-7